189 related articles for article (PubMed ID: 34224341)
21. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
[TBL] [Abstract][Full Text] [Related]
22. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
[No Abstract] [Full Text] [Related]
23. Prospective acceptability of a multipurpose technology (MPT) implant in preclinical development to prevent HIV and unplanned pregnancy: Qualitative insights from women end users and health care providers in South Africa and Zimbabwe.
Nkomo S; Makoni W; Shapley-Quinn MK; Luecke E; Mbatsane E; Manenzhe K; Ahmed K; Johnson LM; Mahaka I; van der Straten A
PLoS One; 2023; 18(5):e0285711. PubMed ID: 37195918
[TBL] [Abstract][Full Text] [Related]
24. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
[TBL] [Abstract][Full Text] [Related]
25. Multipurpose prevention technologies: products in development.
Friend DR; Clark JT; Kiser PF; Clark MR
Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
[TBL] [Abstract][Full Text] [Related]
26. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
[TBL] [Abstract][Full Text] [Related]
27. Biomedical, socio-behavioral, and implementation science gaps in multipurpose prevention technology research.
Cummins JE; Allen CL; Lee S; Senn TE
Front Reprod Health; 2023; 5():1244659. PubMed ID: 37744288
[TBL] [Abstract][Full Text] [Related]
28. "I felt like a TRIO champion": end-user perspectives on their role as co-designers of multi-purpose technologies.
Agot K; Lutnick A; Shapley-Quinn MK; Ahmed K; Okello T; van der Straten A;
Gates Open Res; 2020; 4():163. PubMed ID: 33870103
[No Abstract] [Full Text] [Related]
29. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
Montgomery ET; Beksinska M; Mgodi N; Schwartz J; Weinrib R; Browne EN; Mphili N; Musara P; Jaggernath M; Ju S; Smit J; Chirenje ZM; Doncel GF; van der Straten A
J Int AIDS Soc; 2019 May; 22(5):e25283. PubMed ID: 31069957
[TBL] [Abstract][Full Text] [Related]
30. Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa.
Kutywayo A; Mataboge P; Mthimkhulu N; Martin CE; Muhwava LS; Mazibuko M; Makalela N; Kwatsha K; Butler V; Mullick S
Front Reprod Health; 2024; 6():1249750. PubMed ID: 38444890
[TBL] [Abstract][Full Text] [Related]
31. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
[TBL] [Abstract][Full Text] [Related]
32. Prioritizing multipurpose prevention technology development and investments using a target product profile.
Romano J; Manning J; Hemmerling A; McGrory E; Holt BY
Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707
[TBL] [Abstract][Full Text] [Related]
33. Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy.
Cohen JA; Mastroianni AC; Macklin R
Int J Gynaecol Obstet; 2014 Nov; 127(2):221-4. PubMed ID: 25113651
[TBL] [Abstract][Full Text] [Related]
34. Hair salons and stylist-client social relationships as facilitators of community-based contraceptive uptake in KwaZulu-Natal, South Africa: a qualitative analysis.
Wara NJ; Psaros C; Govere S; Dladla N; Stuckwisch A; Zionts D; Jarolimova J; Bassett IV
Reprod Health; 2021 Aug; 18(1):178. PubMed ID: 34461925
[TBL] [Abstract][Full Text] [Related]
35. Designing a multipurpose technology for acceptability and adherence.
Tolley EE; Morrow KM; Owen DH
Antiviral Res; 2013 Dec; 100 Suppl(0):S54-9. PubMed ID: 24188706
[TBL] [Abstract][Full Text] [Related]
36. Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability.
Shapley-Quinn MK; Song M; Chen BA; Devlin B; Luecke E; Brown J; Blithe DL; Achilles SL; van der Straten A
Front Reprod Health; 2023; 5():1147628. PubMed ID: 37484873
[TBL] [Abstract][Full Text] [Related]
37. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
[TBL] [Abstract][Full Text] [Related]
38. Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa.
Govender E; Abdool Karim Q
AIDS Care; 2018 Oct; 30(10):1311-1314. PubMed ID: 29914270
[TBL] [Abstract][Full Text] [Related]
39. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
40. Toward an intravaginal device to detect risk of preterm labor: a user-centered design approach in Sub-Saharan Africa.
Smith E; Milford C; Ngure K; Newmann S; Thuo NB; Berrios S; Beksinska ME; Mugo N; Rand L
Reprod Health; 2022 Jul; 19(1):171. PubMed ID: 35907873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
